Works matching IS 03618609 AND DT 2023 AND VI 98 AND IP 5

Results: 25
    1
    2

    Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 750, doi. 10.1002/ajh.26895
    By:
    • Arulogun, Suzanne O.;
    • Brian, Duncan;
    • Goradia, Harshita;
    • Cooney, Aaron;
    • Menne, Tobias;
    • Koo, RayMun;
    • O'Neill, Aideen T.;
    • Vos, Josephine M. I.;
    • Pratt, Guy;
    • Turner, Deborah;
    • Marshall, Kirsty;
    • Manos, Kate;
    • Anderson, Claire;
    • Gavriatopoulou, Maria;
    • Kyriakou, Charalampia;
    • Kersten, Marie J.;
    • Minnema, Monique C.;
    • Koutoumanou, Eirini;
    • El‐Sharkawi, Dima;
    • Linton, Kim
    Publication type:
    Article
    3
    4
    5

    Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 730, doi. 10.1002/ajh.26891
    By:
    • Katodritou, Eirini;
    • Kastritis, Efstathios;
    • Dalampira, Dimitra;
    • Delimpasi, Sosana;
    • Spanoudakis, Emmanouil;
    • Labropoulou, Vasiliki;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Gkioka, Annita‐Ioanna;
    • Giannakoulas, Nikos;
    • Kanellias, Nikolaos;
    • Papadopoulou, Theodosia;
    • Sevastoudi, Aggeliki;
    • Michalis, Eyrydiki;
    • Papathanasiou, Maria;
    • Kotsopoulou, Maria;
    • Sioni, Anastasia;
    • Triantafyllou, Theodora;
    • Daiou, Aikaterini;
    • Papadatou, Mavra;
    • Kyrtsonis, Marie‐Christine
    Publication type:
    Article
    6
    7

    Phenotypic characterization of disease‐initiating stem cells in JAK2‐ or CALR‐mutated myeloproliferative neoplasms.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 770, doi. 10.1002/ajh.26889
    By:
    • Ivanov, Daniel;
    • Milosevic Feenstra, Jelena D.;
    • Sadovnik, Irina;
    • Herrmann, Harald;
    • Peter, Barbara;
    • Willmann, Michael;
    • Greiner, Georg;
    • Slavnitsch, Katharina;
    • Hadzijusufovic, Emir;
    • Rülicke, Thomas;
    • Dahlhoff, Maik;
    • Hoermann, Gregor;
    • Machherndl‐Spandl, Sigrid;
    • Eisenwort, Gregor;
    • Fillitz, Michael;
    • Sliwa, Thamer;
    • Krauth, Maria‐Theresa;
    • Bettelheim, Peter;
    • Sperr, Wolfgang R.;
    • Koller, Elisabeth
    Publication type:
    Article
    8

    DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 739, doi. 10.1002/ajh.26888
    By:
    • Huntington, Scott F.;
    • Schuster, Stephen J.;
    • Ding, Wei;
    • Koehler, Amber B.;
    • Brander, Danielle M.;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Tun, Han W.;
    • Moustafa, Muhamad Alhaj;
    • Iqbal, Madiha;
    • He, Wei;
    • Kearney, Albert S.;
    • McKinlay, Timothy P.;
    • Gui, Min;
    • Mato, Anthony R.
    Publication type:
    Article
    9

    Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 760, doi. 10.1002/ajh.26892
    By:
    • Lo, Min‐Yen;
    • Tsai, Xavier Cheng‐Hong;
    • Lin, Chien‐Chin;
    • Tien, Feng‐Ming;
    • Kuo, Yuan‐Yeh;
    • Lee, Wan‐Hsuan;
    • Peng, Yen‐Ling;
    • Liu, Ming‐Chih;
    • Tseng, Mei‐Hsuan;
    • Hsu, Cheng‐An;
    • Chen, Jui‐Che;
    • Lin, Liang‐In;
    • Sun, Hsun‐I;
    • Chuang, Yi‐Kuang;
    • Ko, Bor‐Sheng;
    • Tang, Jih‐Luh;
    • Yao, Ming;
    • Chou, Wen‐Chien;
    • Hou, Hsin‐An;
    • Tien, Hwei‐Fang
    Publication type:
    Article
    10

    The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. E119, doi. 10.1002/ajh.26886
    By:
    • Diamantopoulos, Panagiotis T.;
    • Solomou, Elena;
    • Symeonidis, Argiris;
    • Pappa, Vasiliki;
    • Kotsianidis, Ioannis;
    • Galanopoulos, Athanasios;
    • Pontikoglou, Charalampos;
    • Anagnostopoulos, Achilles;
    • Vassilopoulos, George;
    • Zikos, Panagiotis;
    • Hatzimichael, Eleftheria;
    • Papaioannou, Maria;
    • Megalakaki, Aekaterini;
    • Vassilakopoulos, Theodoros;
    • Dimou, Maria;
    • Tsokanas, Dimitrios;
    • Papoutselis, Menelaos‐Konstantinos;
    • Papageorgiou, Sotirios;
    • Kourakli, Alexandra;
    • Papadaki, Helen
    Publication type:
    Article
    11
    12
    13

    Relevance of Howell‐Jolly body counts for measuring spleen function in sickle cell disease.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. E110, doi. 10.1002/ajh.26879
    By:
    • Pourdieu, Charlotte;
    • El Hoss, Sara;
    • Le Roux, Enora;
    • Pages, Justine;
    • Koehl, Bérengère;
    • Missud, Florence;
    • Holvoet, Laurent;
    • Ithier, Ghislaine;
    • Benkerrou, Malika;
    • Haouari, Zinedine;
    • Da Costa, Lydie;
    • El Nemer, Wassim;
    • Laurance, Sandrine;
    • Aronovicz, Yves Colin;
    • Le Van Kim, Caroline;
    • Fenneteau, Odile;
    • Lainey, Elodie;
    • Brousse, Valentine
    Publication type:
    Article
    14
    15

    Germline and somatic RUNX1 variants in a pediatric bone marrow failure cohort.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. E102, doi. 10.1002/ajh.26874
    By:
    • Yamamori, Ayako;
    • Hamada, Motoharu;
    • Muramatsu, Hideki;
    • Wakamatsu, Manabu;
    • Hama, Asahito;
    • Narita, Atsushi;
    • Tsumura, Yusuke;
    • Yoshida, Taro;
    • Doi, Takehiko;
    • Terada, Kazuki;
    • Higa, Takeshi;
    • Yamamoto, Nobuyuki;
    • Miura, Hiroki;
    • Shiota, Mitsutaka;
    • Watanabe, Kenichiro;
    • Yoshida, Nao;
    • Maemura, Ryo;
    • Imaya, Masayuki;
    • Miwata, Shunsuke;
    • Narita, Kotaro
    Publication type:
    Article
    16
    17
    18

    Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib‐dexamethasone versus physician's choice.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 720, doi. 10.1002/ajh.26866
    By:
    • Sanchorawala, Vaishali;
    • Wechalekar, Ashutosh D.;
    • Kim, Kihyun;
    • Schönland, Stefan O.;
    • Landau, Heather J.;
    • Kwok, Fiona;
    • Suzuki, Kenshi;
    • Dispenzieri, Angela;
    • Merlini, Giampaolo;
    • Comenzo, Raymond L.;
    • Cherepanov, Dasha;
    • Hayden, Vanessa C.;
    • Kumar, Arun;
    • Labotka, Richard;
    • Faller, Douglas V.;
    • Kastritis, Efstathios
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25

    Issue Information.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 701, doi. 10.1002/ajh.26608
    Publication type:
    Article